Lexaria Bioscience Corp. (LEXX) Balance Sheet

NASDAQ: LEXXAssets, liabilities, debt and equity over 10 years.

LEXX balance sheet, FY2025

August 31, 2025 · U.S. dollars

$4.2M assets = $1.6M liabilities + $2.6M equity

Both columns are drawn to the same scale: what LEXX owns equals what it owes plus shareholders’ equity. Hover a block for its value.

LEXX financial health

Current ratio2.32

Comfortable · current assets cover current liabilities 2.32×

Debt / equity0.04

Low leverage · $0.04 of debt for each $1 of equity

Equity / assets71.6%

Equity-funded · of assets funded by shareholders

Cash / debt1,799.7%

Cash covers debt · cash & short-term investments vs total debt

Goodwill & intangibles7.4%

Mostly tangible · of total assets

Descriptive bands, not a rating. Fiscal FY2025.

LEXX balance sheet trends, FY2016–FY2025

Lexaria Bioscience Corp. balance sheet trends
Metric	Then	Latest	Change
Total assets	$566,638FY2016	$4.2MFY2025	+24.8%/yr
Total liabilities	$478,881FY2016	$1.6MFY2025	+14.1%/yr
Shareholders’ equity	$266,045FY2016	$3.0MFY2025	+30.8%/yr
Cash & short-term investments	$93,409FY2016	$2.0MFY2025	+40.3%/yr
Total debt	$45,000FY2016	$109,320FY2025	+10.4%/yr
Net cash (debt)	$48,409FY2016	$1.9MFY2025	+$1.8M
Working capital	$76,285FY2016	$2.0MFY2025	+$1.9M
Book value per share	$6.90FY2023	$2.49FY2025	−39.9%/yr
Current ratio	1.18FY2016	2.32FY2025	+1.15
Debt / equity	0.17FY2016	0.04FY2025	−0.13
Shares outstanding	441KFY2023	1.2MFY2025	+65.0%/yr

Change is the average annual growth (CAGR) or the difference between the first and latest year.

LEXX assets

Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current

LEXX liabilities and equity

Current liabilitiesLong-term debtOther long-term liabilitiesEquity

LEXX debt vs cash

Total debtCash & ST investmentsNet cash (debt)

Debt includes short- and long-term borrowings and, where reported, lease obligations.

LEXX balance sheet

Lexaria Bioscience Corp. annual balance sheet
	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016
Assets
Cash & short-term investments	$2.0M	$6.6M	$1.5M	$6.2M	$11.8M	$1.3M	$1.3M	$1.7M	$2.5M	$93,409
Cash & equivalents	$1.8M	$6.5M	$1.4M	$5.8M	$10.9M	$1.3M	$1.3M	$1.7M	$2.5M	$93,409
Short-term investments	$165,360	$55,807	$125,642	$347,335	$833,841	$19,321	$64,214	$10,151	—	—
Receivables	$174,000	$154,477	$175,245	$201,784	$342,401	$313,925	$273,145	$265,751	$45,293	$131,083
Inventory	$0	$0	$1	$38,418	$29,648	$116,871	$127,396	$87,233	$67,174	$134,724
Other current assets	$1.3M	$1.2M	$546,782	$576,761	$319,253	$182,095	$68,927	$193,732	$149,691	$150,950
Total current assets	$3.5M	$7.9M	$2.2M	$7.0M	$12.4M	$1.9M	$1.8M	$2.3M	$2.8M	$510,166
Property, plant & equipment (net)	$334,945	$389,552	$421,589	$367,949	$459,254	$610,277	$591,263	$1,237	$1,856	$2,475
Goodwill & intangible assets	$307,818	$516,676	$462,625	$488,462	$364,623	$292,000	$265,127	$146,538	$62,827	$53,997
Long-term investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Other non-current assets	$64,013	$63,575	$0	$0	$0	$0	$0	$0	$0	$0
Total assets	$4.2M	$8.9M	$3.1M	$7.8M	$13.3M	$2.8M	$2.7M	$2.4M	$2.9M	$566,638
Liabilities
Accounts payable	$1.4M	$1.1M	$225,038	$120,146	$104,891	$45,080	$31,463	$14,378	$32,574	$90,010
Short-term debt	$30,417	$28,047	$27,794	$42,587	$47,330	$36,038	—	—	—	—
Deferred revenue	—	$4,963	−$225,038	—	—	$44,255	—	−$7,855	$17,083	$12,500
Total current liabilities	$1.5M	$1.1M	$267,735	$194,036	$153,276	$225,917	$184,507	$43,640	$92,347	$433,881
Long-term debt	$0	$0	$0	$0	$0	$30,670	$0	$0	$0	$0
Lease obligations	$109,320	$137,366	$163,967	$49,988	$89,393	$125,431	—	—	—	—
Other long-term liabilities	$78,903	$109,319	$136,173	$7,401	$49,989	$89,393	$72,795	$35,785	$49,657	$45,000
Total liabilities	$1.6M	$1.2M	$403,908	$201,437	$203,265	$345,980	$184,507	$43,640	$92,347	$478,881
Shareholders' equity
Common stock & paid-in capital	$19,559	$15,810	$8,091	$5,951	$5,727	$3,001	$78,787	$75,533	$67,976	$51,288
Retained earnings (deficit)	−$63.5M	−$51.6M	−$45.8M	−$39.1M	−$31.8M	−$27.8M	−$23.9M	−$19.8M	−$13.2M	−$11.3M
Accumulated other comprehensive income	−$70,335	−$19,816	—	$0	$0	$0	−$58,137	−$14,247	$0	$0
Minority interest	−$386,942	−$377,349	−$364,040	−$316,414	—	—	—	—	—	—
Total shareholders' equity	$3.0M	$8.0M	$3.0M	$7.9M	$13.3M	$2.5M	$2.4M	$2.4M	$3.0M	$266,045
Key figures
Total debt	$109,320	$137,366	$163,967	$49,988	$97,319	$156,101	—	$7,855	$42,690	$45,000
Net cash (debt)	$1.9M	$6.4M	$1.3M	$6.1M	$11.7M	$1.2M	—	$1.7M	$2.5M	$48,409
Working capital	$2.0M	$6.8M	$1.9M	$6.8M	$12.3M	$1.7M	$1.6M	$2.2M	$2.7M	$76,285
Tangible book value	$2.7M	$7.5M	$2.6M	$7.5M	$12.9M	$2.2M	$2.1M	$2.2M	$2.9M	$212,048
Book value per share	$2.49	$9.73	$6.90	—	—	—	—	—	—	—
Shares outstanding	1.2M	826K	441K	—	—	—	—	—	—	—
Current ratio	2.32	7.18	8.22	35.96	81.18	8.53	9.86	52.34	30.27	1.18
Quick ratio	1.43	6.10	6.17	32.79	78.90	7.20	8.79	45.90	27.92	0.52
Debt / equity	0.04	0.02	0.05	0.01	0.01	0.06	—	0.00	0.01	0.17
Equity / assets	71.6%	90.6%	98.7%	101.5%	100.0%	89.3%	89.1%	98.2%	105.1%	47.0%

Lexaria Bioscience Corp. quarterly balance sheet
	May '26	Feb '26	Nov '25	Aug '25	May '25	Feb '25	Nov '24	Aug '24	May '24	Feb '24	Nov '23	Aug '23
Assets
Cash & short-term investments	$3.6M	$5.3M	$4.4M	$2.0M	$4.6M	$6.5M	$8.1M	$6.6M	$8.5M	$4.8M	$2.0M	$1.5M
Cash & equivalents	$3.5M	$5.1M	$4.3M	$1.8M	$4.6M	$6.5M	$8.1M	$6.5M	$8.5M	$4.7M	$2.0M	$1.4M
Short-term investments	$142,103	$141,266	$143,267	$165,360	$33,540	$73,915	$39,875	$55,807	$46,307	$87,699	$72,427	$125,642
Receivables	$48,998	$42,029	$88,044	$174,000	$174,000	$174,000	$263,491	$84,000	$91,760	$357,090	$127,760	$175,245
Inventory	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$1	$1
Other current assets	$398,765	$458,846	$850,585	$1.3M	$1.0M	$1.0M	$444,121	$1.3M	$496,231	$266,796	$539,281	$546,782
Total current assets	$4.1M	$5.8M	$5.4M	$3.5M	$5.8M	$7.7M	$8.8M	$7.9M	$9.1M	$5.4M	$2.7M	$2.2M
Property, plant & equipment (net)	$313,432	$334,949	$315,605	$334,945	$354,154	$358,329	$398,646	$389,552	$362,605	$376,312	$390,204	$421,589
Goodwill & intangible assets	$339,016	$318,058	$308,060	$307,818	$516,420	$506,180	$505,373	$516,676	$498,878	$519,253	$494,377	$462,625
Long-term investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Other non-current assets	$64,014	$64,014	$64,013	$64,013	$64,014	$88,659	$64,014	$63,575	$63,575	$39,494	$48,559	$0
Total assets	$4.8M	$6.5M	$6.1M	$4.2M	$6.7M	$8.7M	$9.8M	$8.9M	$10.0M	$6.4M	$3.6M	$3.1M
Liabilities
Accounts payable	$350,377	$36,195	$1.3M	$1.4M	$1.4M	$1.3M	$262,094	$1.1M	$121,307	$47,657	$92,127	$225,038
Short-term debt	$33,035	$32,060	$31,101	$30,417	$29,872	$29,337	$28,812	$28,047	$27,260	$26,399	$25,554	$27,794
Deferred revenue	—	—	—	—	—	—	—	$4,963	—	—	—	—
Total current liabilities	$383,412	$214,671	$1.5M	$1.5M	$1.5M	$1.8M	$297,798	$1.1M	$156,048	$81,717	$124,523	$267,735
Long-term debt	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Lease obligations	$86,714	$94,386	$101,920	$109,320	$116,586	$123,723	$130,732	$137,366	$142,587	$148,885	$155,071	$163,967
Other long-term liabilities	$53,679	$62,325	$70,819	$78,903	$86,714	$94,386	$101,920	$109,319	$115,327	$122,486	$129,517	$136,173
Total liabilities	$437,091	$276,997	$1.5M	$1.6M	$1.6M	$1.9M	$399,718	$1.2M	$271,375	$204,203	$254,040	$403,908
Shareholders' equity
Common stock & paid-in capital	$24,788	$24,888	$22,226	$19,559	$19,559	$17,559	$17,453	$15,810	$15,810	$12,388	$10,311	$8,091
Retained earnings (deficit)	−$68.5M	−$66.5M	−$65.1M	−$63.5M	−$60.8M	−$57.0M	−$54.3M	−$51.6M	−$49.4M	−$47.6M	−$46.9M	−$45.8M
Accumulated other comprehensive income	−$46,473	−$55,444	−$76,079	−$70,335	−$81,073	−$118,246	−$22,991	−$19,816	−$21,866	−$20,626	$4,372	—
Minority interest	−$393,970	−$392,191	−$389,438	−$386,942	−$385,552	—	—	—	—	—	—	—
Total shareholders' equity	$4.7M	$6.6M	$4.9M	$3.0M	$5.6M	$7.1M	$9.8M	$8.0M	$10.1M	$6.5M	$3.7M	$3.0M
Key figures
Total debt	$86,714	$94,386	$101,920	$109,320	$116,586	$123,723	$130,732	$137,366	$142,587	$148,885	$155,071	$163,967
Net cash (debt)	$3.5M	$5.2M	$4.3M	$1.9M	$4.5M	$6.4M	$8.0M	$6.4M	$8.4M	$4.6M	$1.9M	$1.3M
Working capital	$3.7M	$5.6M	$3.9M	$2.0M	$4.3M	$5.9M	$8.5M	$6.8M	$8.9M	$5.3M	$2.6M	$1.9M
Tangible book value	$4.4M	$6.3M	$4.6M	$2.7M	$5.0M	$6.6M	$9.3M	$7.5M	$9.6M	$6.0M	$3.2M	$2.6M
Book value per share	$2.87	$4.05	$3.45	$2.29	$4.55	$6.12	$8.80	$9.19	$10.96	$9.09	$6.20	$6.90
Shares outstanding	1.7M	1.6M	1.4M	1.3M	1.2M	1.2M	1.1M	875K	924K	718K	603K	441K
Current ratio	10.60	26.88	3.68	2.32	3.90	4.24	29.64	7.18	58.27	66.29	21.63	8.22
Quick ratio	9.56	24.74	3.10	1.43	3.23	3.69	28.15	6.04	55.09	63.02	17.30	6.17
Debt / equity	0.02	0.01	0.02	0.04	0.02	0.02	0.01	0.02	0.01	0.02	0.04	0.05
Equity / assets	99.1%	101.8%	81.2%	71.6%	82.4%	82.3%	99.8%	90.6%	101.0%	102.7%	103.2%	98.7%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed November 28, 2025); data from EODHD.

LEXX financial position

At the end of fiscal 2025 (August 31, 2025), Lexaria Bioscience had total assets of $4.2 million (down 52.9% from a year earlier), total liabilities of $1.6 million and shareholders' equity of $3.0 million. It held $2.0 million in cash and short-term investments against $0.1 million of debt, a net cash position of $1.9 million. Its current ratio was 2.32. In the latest quarter (ended May 31, 2026) total assets were $4.8 million and equity $4.7 million.

Related: LEXX income statement, LEXX cash flow statement, LEXX key metrics. See the LEXX stock overview for the latest quote and news.

LEXX balance sheet FAQ

What are Lexaria Bioscience's total assets?

Lexaria Bioscience reported total assets of $4.2 million at the end of fiscal 2025 (August 31, 2025), compared with $8.9 million a year earlier.

How much debt does Lexaria Bioscience have?

Lexaria Bioscience had $0.1 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.04.

How much cash does Lexaria Bioscience have?

Lexaria Bioscience held $2.0 million in cash and short-term investments at the end of fiscal 2025; with $0.1 million of debt that is net cash of $1.9 million.

What is Lexaria Bioscience's book value?

Lexaria Bioscience's shareholders' equity (book value) was $3.0 million at the end of fiscal 2025, or $2.49 per share.

What is Lexaria Bioscience's current ratio?

Lexaria Bioscience had current assets of $3.5 million and current liabilities of $1.5 million, a current ratio of 2.32 (it can cover its short-term obligations).

How much goodwill does Lexaria Bioscience have?

Lexaria Bioscience carried $0.3 million of goodwill and intangible assets, 7.4% of total assets, at the end of fiscal 2025.